Iovance Biotherapeutics's total assets for Q1 2025 were $966.74M, an increase of 6.19% from the previous quarter. IOVA total liabilities were $198.88M for the fiscal quarter, a -0.57% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.